Mark Murcko's most recent trade in Relay Therapeutics Inc was a trade of 136,681 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Mark Murcko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 136,681 | 136,681 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Mark Murcko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Mark Murcko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 66,055 | 66,055 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Mark Murcko | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 08 Sep 2022 | 25,000 | 996,952 | - | 30.0 | 748,750 | Common Stock |
| Relay Therapeutics Inc | Mark Murcko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 41,597 | 41,597 | - | - | Stock Option (Right to Buy) |